Good science is not necessarily good business
Strong science alone will not get a device to patients. Four insights for medtech founders on aligning clinical need, funding and manufacturing partners early.
-
-
Scrappy is not the same as cheap
Every dollar you spend is a trade-off. A dollar spent on one thing is a dollar that is not available for the next. Some of that money costs ownership. When it does, overspending means founders and early investors give up a bigger share of what they built through dilution. That is why the instinct to…
-
Medtech advantage is built together
Reflections from Bernstein Private Wealth Management’s Medical Devices Study Group We spend a lot of time with teams who are building the future of medtech. They are solving real problems, making high-stakes decisions and trying to create momentum with limited time and resources. That work can feel lonely at times. It doesn’t have to be….
-
10 MORE mistakes medtech startups make — and how to avoid them
In our previous article, we explored ten common mistakes medtech startups make while developing and commercializing a medical device. This article continues that conversation with mistakes 11 through 20—additional challenges that can create avoidable delays, costs and barriers to adoption. Bringing a medical device to market requires much more than a strong product and a clear clinical need….
-
10 Mistakes medtech startups make — and how to avoid them
Bringing a medical device to market is never just a product challenge. It is a market challenge, a regulatory challenge, a reimbursement challenge, a workflow challenge and ultimately a credibility challenge. Startups that understand this early tend to move faster, waste less capital and build stronger businesses. Startups that do not often find themselves solving…
-
Pathways to Exit: What We Learned at the 2026 MedTech Roadshow
What does it really take to build a medtech company that gets acquired, adopted and valued? Our 2026 MedTech Roadshow brought together founders, investors and industry leaders to explore the decisions that shape a company’s future long before exit — from regulatory and clinical strategy to commercialization, manufacturing and the real drivers of market adoption. With two stops on our 2026 tour: Houston,…
-
🎄 The Medtech Product Documentation Naughty & Nice List
A Startup-Friendly Guide to Staying on the Right Side of Regulatory Expectations In the world of medtech innovation, documentation isn’t the glamorous part of bringing a device to life, but it is one of the most critical. Great documentation protects your company, accelerates your regulatory path, and helps you scale. Poor documentation? It slows you down,…
-
The Regulatory Naughty & Nice List: A Holiday Guide for MedTech Startups
Because Santa isn’t the only one checking twice… your regulatory team is too. The holiday season has a way of making all of us reflect—on what we’ve built, what we’ve learned, and what we might need to tighten up going into the new year. For medtech startups, it’s also the perfect moment to pause and…
-
Burning Down Technical Risk: A Critical Step for Medical Device Startups
Technical risk, the potential for technological challenges or failures that could hinder development or commercialization, is a significant concern for medical device startups. Proactively addressing and mitigating technical risk is essential to attracting investors and achieving long-term success. 1. Invest in Research and Development Allocate sufficient resources to research and development (R&D) to ensure your…
-
Navigating Challenges in the Medical Device Startup Landscape
The world of medical device startups is never simple. FDA layoffs, NIH cuts, disruptions at CMS, and fluctuating tariffs have caused the stock market to be unpredictable. Lately, the conditions for running a medical device startup have become even more challenging. So, what can you do to thrive in this environment? Avio’s Insights for Medical…
